Charles River Laboratorie... (CRL)
NYSE: CRL
· Real-Time Price · USD
166.36
9.90 (6.33%)
At close: Oct 01, 2025, 1:42 PM
6.33% (1D)
| Bid | 165.46 |
| Market Cap | 8.19B |
| Revenue (ttm) | 4.03B |
| Net Income (ttm) | -69.22M |
| EPS (ttm) | -1.29 |
| PE Ratio (ttm) | -128.96 |
| Forward PE | 13.61 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 166.54 |
| Volume | 520,315 |
| Avg. Volume (20D) | 881,066 |
| Open | 156.06 |
| Previous Close | 156.46 |
| Day's Range | 156.06 - 167.19 |
| 52-Week Range | 91.86 - 230.02 |
| Beta | 1.47 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for CRL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCharles River Laboratories International Inc. is scheduled to release its earnings on
Nov 5, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
-10.25%
CRL stock has given up its prior gain. Charles Riv...
Unlock content with
Pro Subscription
1 month ago
-10.25%
Charles River shares are trading higher after the company reported better-than-expected Q2 adjusted EPS and sales.
